J. Delaney

First name
J.
Middle name
A.
Last name
Delaney
Dial, S. ., Delaney, J. A., Barkun, A. N., & Suissa, S. . (2005). Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. Jama. http://doi.org/10.1001/jama.294.23.2989
Delaney, J. A., Opatrny, L. ., Brophy, J. M., & Suissa, S. . (2007). Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding. Cmaj. http://doi.org/10.1503/cmaj.070186
Filion, K. B., Delaney, J. A., Brophy, J. M., Ernst, P. ., & Suissa, S. . (2007). The impact of over-the-counter simvastatin on the number of statin prescriptions in the United Kingdom: a view from the General Practice Research Database. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.1314
Delaney, J. A., Daskalopoulou, S. S., Brophy, J. M., Steele, R. J., Opatrny, L. ., & Suissa, S. . (2007). Lifestyle variables and the risk of myocardial infarction in the general practice research database. BMC Cardiovasc Disord. http://doi.org/10.1186/1471-2261-7-38
Daskalopoulou, S. S., Delaney, J. A., Filion, K. B., Brophy, J. M., Mayo, N. E., & Suissa, S. . (2008). Discontinuation of statin therapy following an acute myocardial infarction: a population-based study. Eur Heart J. http://doi.org/10.1093/eurheartj/ehn346
Opatrny, L. ., Delaney, J. A., & Suissa, S. . (2008). Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look. Br J Clin Pharmacol. http://doi.org/10.1111/j.1365-2125.2008.03154.x
Delaney, J. A., Schneider-Lindner, V. ., Brassard, P. ., & Suissa, S. . (2008). Mortality after infection with methicillin-resistant Staphylococcus aureus (MRSA) diagnosed in the community. BMC Med. http://doi.org/10.1186/1741-7015-6-2
Delaney, J. A., Moodie, E. E., & Suissa, S. . (2008). Validating the effects of drug treatment on blood pressure in the General Practice Research Database. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.1553
Delaney, J. A., Daskalopoulou, S. S., & Suissa, S. . (2009). Traditional versus marginal structural models to estimate the effectiveness of beta-blocker use on mortality after myocardial infarction. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.1676
Suissa, D. ., Delaney, J. A., Dial, S. ., & Brassard, P. . (2012). Non-steroidal anti-inflammatory drugs and the risk of Clostridium difficile-associated disease. Br J Clin Pharmacol. http://doi.org/10.1111/j.1365-2125.2012.04191.x